Bailard, Inc. Cumberland Pharmaceuticals Inc Transaction History

Bailard, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 16, 2020	SELL	$3.45 - $5.33 $40,765 - $62,979	-11,816 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$4.73 - $6.4 $12,771 - $17,280	-2,700 Reduced 18.6%	11,816 $70,000
Q2 2019 Jul 26, 2019	BUY	$5.35 - $6.8 $77,660 - $98,708	14,516 New	14,516 $92,000

1.97M

44.2K

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $34.2M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.